EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury

Chrysanthos D Christou iD, Fayyad Jaradat, Jonathon Olsburgh iD, Steven Sacks, Theodoros Kassimatis iD

Journal of the American Society of Nephrology · 2026-01 · 37 (1) · 193-207

DOI: 10.1681/asn.0000000826 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 22.07.2025. Verfasst von Chrysanthos D Christou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Directorate of Transplant, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. Hauptthemen laut MEDLINE: Reperfusion Injury, Kidney Transplantation, Complement Inactivating Agents, Complement System Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemia-reperfusion injury (IRI) is an unavoidable consequence of kidney transplantation and a major contributor to delayed graft function (DGF). DGF, traditionally defined as the need for dialysis within the first week post-transplant, is linked to inferior graft and patient outcomes, prolonged hospitalization, and higher health care costs. IRI begins with tissue hypoxia, which triggers an inflammatory response on reperfusion. The renal tubule plays a critical role in complement synthesis, with local activation driving inflammation and graft immunogenicity more than circulating liver-derived complement. The lectin pathway is a key initiator of complement activation in hypoxic renal tubules, primarily through collectin-11's interaction with glycan ligands on hypoxic cells, with further amplification through the alternative pathway. Despite promising preclinical results, systemic complement inhibitors have not significantly improved DGF in clinical studies, likely due to inefficient targeting of ischemic renal tubules. Machine perfusion offers a novel approach to delivering therapeutics directly to donor kidneys. Notably, hypothermic machine perfusion has improved DGF rates and early graft outcomes. Emerging targeted delivery systems using extracellular vesicles or nanoparticle-based carriers also promise to deliver therapeutics to the sites of injury. Organ-targeted complement inhibition through machine perfusion or other targeted delivery systems represent compelling strategies for IRI prevention. Finally, multigenic xenografts engineered to prevent complement activation have shown initial promise in overcoming the complement-mediated barriers that continue to challenge allotransplantation in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryKidney TransplantationComplement Inactivating AgentsComplement System ProteinsHumansDelayed Graft FunctionAnimalsComplement Activation

Stichwörter der Autor:innen

clinical trialcomplementischemia-reperfusionkidney transplantation

Substanzen

Complement Inactivating AgentsComplement System Proteins

Autor:innen und Institutionen

  • Directorate of Transplant, Renal and Urology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
  • King's Kidney Care, King's College Hospital, London, United Kingdom.

ORCID-Profile: Chrysanthos D Christou, Jonathon Olsburgh, Theodoros Kassimatis

Zitieren

APA

Christou, C. D., Jaradat, F., Olsburgh, J., Sacks, S., & Kassimatis, T. (2026). Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury. Journal of the American Society of Nephrology, 37(1), 193-207. https://doi.org/10.1681/asn.0000000826

Vancouver

Christou CD, Jaradat F, Olsburgh J, Sacks S, Kassimatis T. Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury. Journal of the American Society of Nephrology. 2026;37(1):193-207. doi:10.1681/asn.0000000826

BibTeX
@article{Christou2026,
  author = {Christou, Chrysanthos D and Jaradat, Fayyad and Olsburgh, Jonathon and Sacks, Steven and Kassimatis, Theodoros},
  title = {Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  volume = {37},
  number = {1},
  pages = {193--207},
  doi = {10.1681/asn.0000000826}
}
Kostenlos starten →